Hypoplastic left heart syndrome is a rare but serious heart condition where the left side of a baby’s heart doesn’t develop properly before birth, making it impossible for the heart to pump enough blood to the body without medical intervention.

Introduction: Who Should Undergo Diagnostics

Diagnosing hypoplastic left heart syndrome can happen at different stages, and knowing when to seek medical attention is crucial for the best possible outcome. This heart condition, often shortened to HLHS, is a congenital heart defect, which means it’s present at birth and develops during the earliest weeks of pregnancy when the baby’s heart is forming.^[1]

Most expectant mothers receive routine prenatal ultrasounds during pregnancy. These are standard imaging tests that create pictures of the developing baby inside the womb. If the basic ultrasound shows any hint of heart abnormalities, doctors will recommend a more detailed examination called a fetal echocardiogram. This specialized test focuses specifically on the baby’s heart and can detect HLHS during the second trimester of pregnancy, often around the 20-week mark.^[3][10]

When HLHS is not detected before birth, newborn babies will typically show warning signs within the first few hours or days after they are born. Parents and caregivers should seek immediate medical attention if their newborn displays any concerning symptoms. These include a bluish or grayish color to the skin, lips, or fingernails—a condition called cyanosis—which happens because the blood doesn’t contain enough oxygen. Other red flags include rapid or difficult breathing, trouble feeding, unusual sleepiness or lack of energy, cool or clammy skin, weak pulses, and a faster-than-normal heart rate.^[1][2]

Healthcare professionals in maternity wards are trained to spot these symptoms during routine newborn examinations. If a baby seems unusually lethargic, isn’t feeding well, or develops the telltale blue tint to their skin, the medical team will begin diagnostic procedures right away. Time matters critically in these situations because HLHS becomes life-threatening once certain temporary blood vessel connections that all babies have at birth begin to close naturally. Without treatment, this condition is fatal within the first hours or days of life.^[3][5]

Classic Diagnostic Methods

Diagnosing hypoplastic left heart syndrome involves several imaging techniques and physical examinations that help doctors see exactly what’s happening with the baby’s heart structure and blood flow. The diagnostic process differs depending on whether the baby is still in the womb or has already been born.

Prenatal Diagnosis

The journey toward diagnosing HLHS often begins during a routine pregnancy ultrasound. These standard imaging tests, which most pregnant women undergo during their second trimester, use sound waves to create pictures of the developing baby. When these images suggest something unusual about the heart’s development, doctors will recommend a more specialized test.^[3][10]

A fetal echocardiogram is essentially an ultrasound that focuses specifically and in great detail on the baby’s heart. This test is completely safe and painless for both mother and baby. It uses the same sound wave technology as regular ultrasounds but provides much more detailed pictures of the heart’s chambers, valves, and blood vessels. The test can show doctors if the left side structures—including the left ventricle, mitral valve, aortic valve, and aorta—are underdeveloped or abnormally small. It can also reveal whether blood is flowing through the heart in an unusual pattern.^[3][7]

Detecting HLHS before birth offers significant advantages. It allows parents time to understand the condition, prepare emotionally and practically for what lies ahead, and make informed decisions about where to deliver the baby. Healthcare professionals typically recommend that babies with HLHS be born at a hospital equipped with a specialized cardiac surgery center, as the baby will need immediate medical intervention after birth.^[10][19]

Postnatal Diagnosis

When HLHS isn’t detected during pregnancy, diagnosis happens soon after birth based on the baby’s symptoms and physical examination findings. A pediatrician or neonatologist will start by carefully examining the newborn. During this physical exam, the doctor listens to the baby’s heart using a stethoscope. They may hear an unusual sound called a heart murmur—a whooshing noise created by blood not flowing properly through the heart. However, babies with HLHS may have only a faint murmur or sometimes no murmur at all, so the absence of this sound doesn’t rule out the condition.^[3][5]

The doctor will also check the baby’s pulses, particularly in the arms and legs. Babies with HLHS often have weak pulses throughout their body because the heart isn’t pumping blood effectively. The healthcare provider will observe the baby’s skin color, looking for the bluish or grayish tint that signals low oxygen levels in the blood. They’ll note whether the baby is breathing rapidly or with difficulty and whether the skin feels cool or clammy to the touch.^[1][2]

Once HLHS is suspected, the most important diagnostic test is an echocardiogram. This is the same type of detailed ultrasound used before birth, but now it’s performed on the newborn baby. The echocardiogram uses sound waves to create moving pictures of the heart, showing exactly how blood flows through the chambers and vessels. The test is completely painless and safe—no needles or radiation are involved.^[10][19]

The echocardiogram can reveal several key features of HLHS. Doctors can see that the left ventricle—the heart’s main pumping chamber—is much smaller than normal. They can identify whether the mitral valve and aortic valve are abnormally small or, in some cases, completely closed off (a condition called atresia). The test also shows if the aorta, the body’s largest blood vessel that carries oxygen-rich blood from the heart to the rest of the body, is underdeveloped and too narrow.^[2][4]

Additionally, the echocardiogram helps doctors see temporary structures that exist in all newborns. These include the ductus arteriosus, a blood vessel connecting the pulmonary artery to the aorta, and the foramen ovale, an opening between the heart’s two upper chambers. In babies with HLHS, these structures are actually keeping the baby alive by allowing blood to bypass the underdeveloped left side of the heart. Understanding whether these connections are open and functioning is critical for planning immediate treatment.^[3][14]

Additional Diagnostic Tools

In some cases, doctors may use additional tests to get a complete picture of the baby’s heart and overall health. An electrocardiogram, or EKG, is a simple test that records the electrical activity of the heart. In babies with HLHS, the EKG typically shows patterns indicating that the right side of the heart is enlarged and working harder than normal. This happens because the right ventricle has to take over the job of pumping blood not just to the lungs but also to the entire body—a task normally handled by the left ventricle.^[8]

Chest X-rays might also be performed. These images can show the size and shape of the heart and can reveal whether fluid has built up in the lungs, which can happen when the heart isn’t working properly. Blood tests help doctors assess the baby’s overall condition, checking oxygen levels, acid-base balance, and organ function. These tests don’t diagnose HLHS directly, but they help the medical team understand how severely the condition is affecting the baby’s body.^[6]

Once HLHS is confirmed, doctors will also look carefully at whether there are any additional heart defects or other health problems. Some babies with HLHS are born prematurely or with low birth weight, and some have other medical conditions that need to be considered when planning treatment. A complete assessment helps the cardiac team create the most appropriate treatment plan for each individual baby.^[8][13]

Diagnostics for Clinical Trial Qualification

Clinical trials are research studies that test new ways to treat, diagnose, or prevent medical conditions. For babies and children with hypoplastic left heart syndrome, participating in clinical trials may offer access to innovative treatments or surgical approaches that aren’t yet widely available. However, not every child with HLHS can join every clinical trial. Researchers establish specific criteria to ensure that the study participants are appropriate for the treatment being tested and that the results will be meaningful.

Standard Diagnostic Criteria

Before a baby or child can be enrolled in a clinical trial for HLHS, doctors must confirm the diagnosis using the same standard diagnostic tests described earlier. A detailed echocardiogram is almost always required. This test documents exactly which structures of the left heart are underdeveloped, how severely, and how blood is flowing through the heart. The echocardiogram provides baseline measurements that researchers will use to compare against results after any experimental treatment.^[2][10]

Clinical trials typically require very precise documentation of the heart’s anatomy. Researchers need to know the exact size of the left ventricle, whether the mitral and aortic valves are simply small or completely closed, how narrow the aorta is, and whether there’s a hole between the upper heart chambers. They also need information about how well the right ventricle is functioning, since this chamber has to do extra work in babies with HLHS. All of these details help researchers determine if a particular child fits the profile needed for their specific study.^[4][7]

Risk Stratification and Assessment

Many clinical trials for HLHS focus on specific subgroups of patients based on their level of risk. Not all babies with HLHS face the same challenges—some have additional complicating factors that make treatment more difficult. Researchers often assess these risk factors as part of the screening process for trial enrollment.^[16]

Factors that increase risk include very low birth weight, premature birth, the presence of other heart defects beyond HLHS, evidence that vital organs have been damaged by poor blood flow, and certain genetic conditions such as Turner syndrome or trisomy 18. If a baby has gone into shock before treatment begins, this also significantly increases risk. Some clinical trials specifically target high-risk patients, while others may exclude them to focus on a more uniform study population.^[2][16]

An important diagnostic criterion for some trials involves assessing whether the opening between the heart’s upper chambers—the atrial septal defect—is large enough. When this opening is small, a condition called “restrictive,” oxygen-rich blood from the lungs has trouble mixing with blood that will go to the body. Babies with restrictive atrial septal defects often become very sick very quickly and may need urgent intervention before they can be considered for certain research protocols.^[8][13]

Specialized Testing for Treatment Protocols

Depending on what a clinical trial is studying, additional diagnostic tests may be required beyond the standard heart imaging. For example, trials investigating new surgical techniques or alternative treatment pathways may require advanced imaging such as cardiac catheterization. This procedure involves threading a thin, flexible tube through blood vessels to the heart, allowing doctors to measure pressures inside the heart chambers and see detailed images of blood flow. While more invasive than an echocardiogram, cardiac catheterization can provide information that helps researchers select the most appropriate candidates for experimental procedures.^[6]

Some research studies focus on understanding the neurological development of children with HLHS, since these children face increased risk of developmental delays. These trials may require brain imaging studies or developmental assessments as part of the enrollment process. Other studies might investigate genetic factors, requiring blood samples for DNA testing to identify specific gene mutations associated with HLHS.^[2][6]

For trials that test new medications or medical therapies, baseline blood tests are typically required. These establish normal values for liver function, kidney function, and other markers that will be monitored throughout the study to ensure the experimental treatment isn’t causing harmful side effects. Regular follow-up testing throughout the trial period helps researchers track both effectiveness and safety.^[17]

Ongoing Monitoring in Research Studies

Once enrolled in a clinical trial, children with HLHS undergo regular diagnostic testing as part of the study protocol. These follow-up tests serve two purposes: they monitor the child’s response to the experimental treatment, and they watch for any unexpected complications. The frequency and type of testing depends on what the trial is investigating.^[13]

Echocardiograms are typically repeated at scheduled intervals to track changes in heart function and structure over time. If the trial involves a new surgical approach, imaging studies help researchers see how well the reconstructed heart is working compared to traditional surgical methods. Blood tests may be repeated to check markers of heart function, organ health, and overall well-being. For studies focused on developmental outcomes, children may undergo periodic neurological or developmental assessments as they grow.^[17]

All of this diagnostic information collected during clinical trials contributes to the medical community’s growing understanding of HLHS and helps researchers develop better treatments for future patients. The rigorous testing protocols ensure that new approaches are thoroughly evaluated for both effectiveness and safety before they become standard practice.